학술논문

A phase 2 study of galunisertib (TGF-b1 Receptor Type i Inhibitor) and sorafenib in patients with advanced hepatocellular carcinoma
Document Type
Article
Source
In: Clinical and Translational Gastroenterology. (Clinical and Translational Gastroenterology, 2019, 10(7))
Subject
Language
English
ISSN
2155384X